IRIS
SCHIRINZI, TOMMASO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.657
EU - Europa 1.160
AS - Asia 1.105
SA - Sud America 12
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 4
Totale 14.943
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.638
SG - Singapore 503
IT - Italia 361
IE - Irlanda 207
CN - Cina 192
KR - Corea 182
HK - Hong Kong 162
UA - Ucraina 123
DE - Germania 114
RU - Federazione Russa 104
GB - Regno Unito 47
FR - Francia 45
SE - Svezia 43
FI - Finlandia 38
PL - Polonia 21
NL - Olanda 18
CA - Canada 17
IN - India 14
ID - Indonesia 13
JO - Giordania 10
BE - Belgio 8
BR - Brasile 8
KG - Kirghizistan 7
CH - Svizzera 5
PT - Portogallo 5
AT - Austria 4
BD - Bangladesh 4
EU - Europa 4
JP - Giappone 4
AL - Albania 3
AU - Australia 3
CZ - Repubblica Ceca 3
DK - Danimarca 3
CL - Cile 2
IL - Israele 2
IR - Iran 2
NZ - Nuova Zelanda 2
RO - Romania 2
SA - Arabia Saudita 2
TH - Thailandia 2
VN - Vietnam 2
AR - Argentina 1
BO - Bolivia 1
ES - Italia 1
GE - Georgia 1
GR - Grecia 1
ME - Montenegro 1
MK - Macedonia 1
MX - Messico 1
NO - Norvegia 1
PA - Panama 1
PH - Filippine 1
RS - Serbia 1
TR - Turchia 1
TW - Taiwan 1
Totale 14.943
Salva come PNG Salva come JPEG
Città #
Wilmington 3.520
Houston 3.111
Woodbridge 2.641
Fairfield 534
Singapore 445
Chandler 363
Ashburn 280
Ann Arbor 231
Seattle 220
Cambridge 187
Dublin 180
Hong Kong 159
Rome 139
Medford 129
Dearborn 110
Santa Clara 109
Jacksonville 90
New York 86
Lawrence 61
Beijing 59
Menlo Park 45
Milan 36
Council Bluffs 31
Moscow 20
San Diego 19
Kraków 18
Zhengzhou 18
Nanjing 16
London 15
Munich 15
Norwalk 15
Seoul 14
Helsinki 13
Jakarta 13
Kunming 13
Toronto 13
Del Norte 12
Hefei 12
Monmouth Junction 12
Boardman 11
Incheon 11
Shanghai 11
Creede 10
Durham 10
Mountain View 10
Amman 9
Redwood City 8
Brussels 7
Center 7
Los Angeles 7
Saint Petersburg 7
Shenzhen 7
Detroit 6
Engelhard 6
Verona 6
Genoa 5
Guangzhou 5
Lagoa de São Francisco 5
Lappeenranta 5
Nuremberg 5
Palermo 5
Palo Alto 5
Phoenix 5
Salt Lake City 5
San Jose 5
Tortona 5
Angri 4
Brescia 4
Frankfurt am Main 4
Fuzhou 4
Louisville 4
Monte Porzio Catone 4
Paris 4
Santarém 4
The Dalles 4
Turin 4
Yeonsu-gu 4
Ariccia 3
Brno 3
Chiswick 3
Chongqing 3
Clearwater 3
Dover 3
Islington 3
Kilburn 3
Mumbai 3
Mülheim 3
Pune 3
São Paulo 3
Taiyuan 3
University Park 3
Warsaw 3
Wuhan 3
Asti 2
Auckland 2
Bologna 2
Changsha 2
Desio 2
Dong Ket 2
Florence 2
Totale 13.298
Salva come PNG Salva come JPEG
Nome #
Early synaptic dysfunction in Parkinson's disease: Insights from animal models 457
Aberrant striatal synaptic plasticity in monogenic parkinsonisms 450
Regional specificity of synaptic plasticity deficits in a knock-in mouse model of DYT1 dystonia 443
Occurrence of Writing Tremor in Patients With Scans Without Evidence of Dopaminergic Deficit 425
Symptomatic nonconvulsive status epilepticus erroneously suggestive of sporadic Creutzfeldt-Jakob disease 416
Impaired intracortical transmission in G2019S leucine rich-repeat kinase Parkinson patients 411
Mild cerebello-thalamo-cortical impairment in patients with normal dopaminergic scans (SWEDD) 410
Altered profile and D2-dopamine receptor modulation of high voltage-activated calcium current in striatal medium spiny neurons from animal models of Parkinson's disease. 398
A clinical and biochemical analysis in the differential diagnosis of idiopathic normal pressure hydrocephalus 397
CSF biomarkers in superficial siderosis: a new tool for diagnosis and evaluation of therapeutic efficacy of deferiprone--a case report 394
Dopamine-dependent CB1 receptor dysfunction at corticostriatal synapses in homozygous PINK1 knockout mice 392
PINK1 heterozygous mutations induce subtle alterations in dopamine-dependent synaptic plasticity 386
Centrality of striatal cholinergic transmission in Basal Ganglia function 382
Double hit mouse model of Parkinson's disease 379
Efficacy and safety profile of prolonged release oxycodone in combination with naloxone (OXN PR) in Parkinson’s disease patients with chronic pain 374
Activation of 5-HT6 receptors inhibits corticostriatal glutamatergic transmission. 368
Exposure to low-dose rotenone precipitates synaptic plasticity alterations in PINK1 heterozygous knockout mice 364
Negative allosteric modulation of mGlu5 receptor rescues striatal D2 dopamine receptor dysfunction in rodent models of DYT1 dystonia 360
Outlining a population "at risk" of Parkinson's disease: Evidence from a case-control study 360
Centrality of early synaptopathy in Parkinson's disease 327
Dietary Vitamin E as a Protective Factor for Parkinson's Disease: Clinical and Experimental Evidence 308
Transient parkinsonism after unilateral midbrain stroke: a compensatory intervention from the healthy side? 307
Promising rodent models in Parkinson's disease 294
Cerebrospinal fluid biomarkers profile of idiopathic normal pressure hydrocephalus 292
Dopaminergic involvement in a drummer with focal dystonia: A case study 288
Continuous dopaminergic stimulation in a patient treated with daytime Levodopa-carbidopa intestinal gel and overnight Rotigotine: a case report 283
Association between physical activity and dementia’s risk factors in patients with Parkinson’s disease 259
Assessment of serum uric acid as risk factor for tauopathies 253
Long-term treatment with rotigotine in drug-naïve PSP patients 234
Comments on: “Complementary and alternative therapies for restless legs syndrome: An evidence-based systematic review” 234
Clinical value of CSF amyloid-beta-42 and tau proteins in Progressive Supranuclear Palsy 226
The effect of postural deformities on back function and pain in patients with Parkinson's disease 226
CSF α-synuclein inversely correlates with non-motor symptoms in a cohort of PD patients 224
Altered profile and D2-dopamine receptor modulation of high voltage-activated calcium current in striatal medium spiny neurons from animal models of Parkinson's disease 217
Pisa Syndrome in Parkinson's Disease: Evidence for Bilateral Vestibulospinal Dysfunction 208
Dystonia as a network disorder: A concept in evolution 194
Blunting neuroinflammation with resolvin D1 prevents early pathology in a rat model of Parkinson’s disease 193
Effectiveness of robot-assisted gait training on motor impairments in people with Parkinson's disease: A systematic review and meta-analysis 190
Technology-Based Objective Measures Detect Subclinical Axial Signs in Untreated, de novo Parkinson's Disease 175
Young-onset and late-onset Parkinson's disease exhibit a different profile of fluid biomarkers and clinical features 164
Involvement of the Chemokine Prokineticin-2 (PROK2) in Alzheimer's Disease: From Animal Models to the Human Pathology 155
Systemic activation of Nrf2 pathway in Parkinson's disease 151
Amyloid-Mediated Cholinergic Dysfunction in Motor Impairment Related to Alzheimer's Disease 145
Technology-based assessment of motor impairment in de novo Parkinson's disease patients: implications for diagnostic accuracy and early identification of distinct phenotypes 134
Cerebrospinal fluid ferritin and siderophages in the diagnosis of superficial cerebral siderosis 127
The influence of postural deformities on neck function and pain in patients with Parkinson's disease 123
Levels of amyloid-beta-42 and CSF pressure are directly related in patients with Alzheimer's disease. 113
A Dual Centre Study of Pain in Parkinson's Disease and Its Relationship with Other Non-Motor Symptoms 110
Transcranial Direct Current Stimolation (tDCS) on PD Patients with Freezing of Gait: Preliminary Findings 99
Adult-onset sporadic chorea: real-world data from a single-centre retrospective study 80
Olfactory Neuron Prokineticin-2 as a Potential Target in Parkinson's Disease 71
Spinal vascular lesions: anatomy, imaging techniques and treatment 69
The Nrf2 induction prevents ferroptosis in Friedreich's Ataxia 62
Clinical course of paroxysmal dyskinesias throughout pregnancy 59
Self-reported needs of patients with Parkinson's disease during COVID-19 emergency in Italy 58
Validation of the Italian version of the PSP Quality of Life questionnaire 51
Assessment of Psychometric Characteristics of Parkinson’s Disease Sleep Scale 2 and Analysis of a Cut-Off Score for Detecting Insomnia in Italian Patients with Parkinson’s Disease: A Validation Study 51
COVID-19: dealing with a potential risk factor for chronic neurological disorders 49
Ischemic injury precipitates neuronal vulnerability in Parkinson{'}s disease: Insights from PINK1 mouse model study and clinical retrospective data 48
Physical activity changes and correlate effects in patients with Parkinson's disease during COVID-19 lockdown 44
Axial postural abnormalities and pain in Parkinson's disease 42
Technology-based therapy-response and prognostic biomarkers in a prospective study of a de novo Parkinson’s disease cohort 42
Prevenzione del rischio di disturbo muscoloscheletrico in lavoratori videoterminalisti affetti da Malattia di Parkinson. Studio ergonomico e riabilitativo 39
Brain Functional Connectivity in de novo Parkinson's Disease Patients Based on Clinical EEG 39
Substance P and Prokineticin-2 are overexpressed in olfactory neurons and play differential roles in persons with persistent post-COVID-19 olfactory dysfunction 38
STN-DBS Induces Acute Changes in β-Band Cortical Functional Connectivity in Patients with Parkinson's Disease 38
Pattern of Mitochondrial Respiration in Peripheral Blood Cells of Patients with Parkinson's Disease 37
Sex hormones differentially contribute to Parkinson disease in males: A multimodal biomarker study 34
Movement disorders in primary central nervous system lymphoma: two unreported cases and a review of literature 34
Parkinson's disease motor progression in relation to the timing of REM sleep behavior disorder presentation: an exploratory retrospective study 32
Pregnancy, fertile life factors, and associated clinical course in PRKN early-onset Parkinson’s disease 30
Band-Specific Altered Cortical Connectivity in Early Parkinson's Disease and its Clinical Correlates 29
Constipation distinguishes different clinical-biochemical patterns in de novo Parkinson's disease 29
Using a Video Device and a Deep Learning-Based Pose Estimator to Assess Gait Impairment in Neurodegenerative Related Disorders: A Pilot Study 29
Motor cortex transcranial direct current stimulation improves non-motor symptoms in early-onset Parkinson’s disease: a pilot study 27
Tau and Amyloid-beta Peptides in Serum of Patients With Parkinson's Disease: Correlations With CSF Levels and Clinical Parameters 26
Exploring the Association Linking Head Position and Sleep Architecture to Motor Impairment in Parkinson’s Disease: An Exploratory Study 25
Neuroimaging findings in leukoencephalopathy with calcifications and cysts: case report and review of the literature 23
Insular and limbic abnormal functional connectivity in early-stage Parkinson’s disease patients with autonomic dysfunction 22
A biological characterization of patients with postmenopausal Parkinson's disease 21
Shaping the course of early-onset Parkinson’s disease: insights from a longitudinal cohort 21
Post-COVID-19 Hyposmia Does Not Exhibit Main Neurodegeneration Markers in the Olfactory Pathway 20
transient MR-angiography changes associated with morphological alterations in epileptic seizure: a short case series 20
Hearing dysfunction heralds an increase in non-motor burden and a worse quality of life in Parkinson’s disease: new insights from non-motor spectrum 17
Clinical and neurochemical correlates of the APOE genotype in early-stage Parkinson's disease 17
Circulating calprotectin as a potential biomarker of persistent olfactory dysfunctions in Post-COVID-19 patients 17
Olfactory Neuron Substance P is Overexpressed in Parkinson's Disease Reflecting Gut Dysfunction 17
Childhood Rapid-Onset Ataxia: Expanding the Phenotypic Spectrum of ATP1A3 Mutations 16
Oral Health and Use of Novel Transbuccal Drug Delivery Systems in Patients with Alzheimer’s and Parkinson’s Disease: A Review 16
Longitudinal gait assessment in a stiff person syndrome 15
Stage-dependent phosphoproteome remodeling of Parkinson's disease blood cells 14
Sex hormones shape EEG-based functional connectivity in early-stage Parkinson’s disease patients 13
Clinico‐Genetic, Imaging and Molecular Delineation of ‐Ataxia: A Multicenter Study of 59 Patients 10
Immunometabolic Signature and Tauopathy Markers in Blood Cells of Progressive Supranuclear Palsy 9
Cortical functional connectivity changes in the body-first and brain-first subtypes of Parkinson's disease 8
Totale 15.327
Salva come PNG Salva come JPEG
Categoria #
all - tutte 40.572
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.572
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.241 0 0 0 0 0 0 411 372 472 378 308 300
2020/20212.669 320 343 292 319 272 316 304 267 44 67 96 29
2021/2022793 31 61 60 40 6 63 143 41 38 64 72 174
2022/2023935 98 84 29 104 74 210 131 74 75 1 37 18
2023/2024532 41 14 24 12 51 113 31 71 16 52 24 83
2024/20251.411 58 505 224 146 86 279 113 0 0 0 0 0
Totale 15.327